Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDSMarcos de Lima, Börje S. Andersson, Daniel R. Couriel et al.|Blood|2004Cited by 422
Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancerIan McNiece, Elizabeth J. Shpall, Roy B. Jones et al.|Blood|2000Cited by 159
Evaluation of the Predictive Value of Her-2/neu Overexpression and p53 Mutations in High-Risk Primary Breast Cancer Patients Treated With High-Dose Chemotherapy and Autologous Stem-Cell TransplantationYago Nieto, Roy B. Jones, Pablo J. Cagnoni et al.|Journal of Clinical Oncology|2000Cited by 62
Incidence of Tumor-Cell Contamination in Leukapheresis Products of Breast Cancer Patients Mobilized With Stem Cell Factor and Granulocyte Colony-Stimulating Factor (G-CSF) or With G-CSF AloneWilbur A. Franklin, Elizabeth J. Shpall, John A. Glaspy et al.|Blood|1999Cited by 57
Immunomagnetic purging of breast cancer from bone marrow for autologous transplantation.Elizabeth J. Shpall, W. P. Peters, I. C. Anderson et al.|PubMed|1991Cited by 56